✦ LIBER ✦

Cytomegalovirus Viremia During Campath-1H Therapy for Relapsed and Refractory Chronic Lymphocytic Leukemia and Prolymphocytic Leukemia

✍ Scribed by Nguyen, Dorothy D.; Cao, Thai M.; Dugan, Kathleen; Starcher, Stacey A.; Fechter, R. Lenn; Coutre, Steven E.

Book ID: 119935724
Publisher: CIG Media Group, LP.
Year: 2002
Tongue: English
Weight: 151 KB
Volume: 3
Category: Article
ISSN: 1526-9655
DOI: 10.3816/clm.2002.n.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Filgrastim and alemtuzumab (Campath-1H)

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia

✍ Lin, T S; Flinn, I W; Lucas, M S; Porcu, P; Sickler, J; Moran, M E; Lucas, D M; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB

Ofatumumab for newly diagnosed and relap

Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia

✍ Reagan, John L ;Castillo, Jorge J 📂 Article 📅 2011 🏛 Expert Reviews 🌐 English ⚖ 914 KB

Treatment of refractory chronic lymphocy

Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infection

✍ Ulrike Heider; Claudia Fleissner; Ivana Zavrski; Christian Jakob; Toralf Dietzel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

5.24 Pentostatin, Alemtuzumab, and Low-D

5.24 Pentostatin, Alemtuzumab, and Low-Dose Rituximab Is Effective Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

✍ Clive S. Zent; Betsy R. LaPlant; Brian Link; Timothy G. Call; Tait D. Shanafelt; 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 87 KB

Adefovir added to lamivudine for hepatit

Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H

✍ Agostino Cortelezzi; Mauro Viganò; Vittorio R. Zilioli; Norma N. Fantini; Maria 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Phase II Study of Lenalidomide and Ritux

Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

✍ Badoux, X. C.; Keating, M. J.; Wen, S.; Wierda, W. G.; O'Brien, S. M.; Faderl, S 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 137 KB